Gain Therapeutics, Inc.
$1.77
-0.03 (-1.67%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +1.1%
- 3 Months
- -3.3%
- YTD
- -45.0%
- 1 Year
- -11.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 108.7%
- Largest decline max drawdown, since Aug 2025
- -62.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.46
Own GANX?
See how GANX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.